Search
for
Sort by
Research 721–750 of 1000+
- Clinical and Hormonal Evaluation of Androgen Excess
- American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: Guide to the Best Practices in the Evaluation and Treatment of Polycystic Ovary Syndrome - Part 1
- Prevalence of polycystic ovary syndrome in women in China: a large community-based study
- The diagnosis of polycystic ovary syndrome in adolescents
- Alopecia and its association with coronary heart disease and cardiovascular risk factors: A meta-analysis
- Polycystic Ovarian Syndrome: Long-Term Health Consequences
- Acne keloidalis nuchae: risk factors and associated disorders – a retrospective study
- Gender-specific risk factors for androgenetic alopecia in the Korean general population: Associations with medical comorbidities and general health behaviors
- [Association between androgenetic alopecia and metabolic syndrome: a meta-analysis].
- POLYCYSTIC OVARY SYNDROME: DIVERSE CLINICAL PRESENTATIONS ACROSS ADOLESCENCE, REPRODUCTIVE AGE, AND MENOPAUSE
- Therapeutic Potential of Vitex negundo for the Treatment of Polycystic Ovarian Disease (PCOD): A Review
- The Experience of SARS-CoV-2 in Patients with Benign Prostatic Hyperplasia: Is There Any Correlation between Them?
- Association between androgenetic alopecia and metabolic syndrome – A case control study
- Triple Hormonal Blockade (ADT3): A Patient’s Perspective
- Metabolic Syndrome, Cardiovascular Disease and the Hair Growth Cycle: Addressing hair growth disruptions using Nourkrin® with Marilex® as a proteoglycan replacement therapy: A concise review
- Follicular Neutrophilic Inflammation (Hidradenitis Suppurativa)
- A cross-sectional, observational study of the clinico-epidemiological profile of female pattern hair loss in Western India and its association with metabolic syndrome
- Risks for metabolic syndrome and cardiovascular diseases in both male and female patients with androgenetic alopecia
- New aspects of vitamin D metabolism and action — addressing the skin as source and target
- COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology
- Comparison clinical and metabolic effects of metformin and pioglitazone in polycystic ovary syndrome
- Testosterone replacement in 49,XXXXY syndrome: andrological, metabolic and neurological aspects
- Activity of type 1 5α-reductase is greater in the follicular infrainfundibulum compared with the epidermis
- Association between Polymorphisms of OCT1 and Metabolic Response to Metformin in Women with Polycystic Ovary Syndrome
- Increase in testosterone metabolism in the rat central nervous system by formalin-induced tonic pain
- Testosterone therapy for women with low sexual desire: a position statement from the Brazilian Society of Endocrinology and Metabolism
- Menopausal Androgen Excess - Associated Cardio-Metabolic Risk: Clues for Ovarian Leydig Cell Tumour (Case Report and Mini-Review of Literature)
- The effect of vitamin D on the hormonal profile of women with polycystic ovarian syndrome: a systematic review and meta-analysis
- Hypoparathyroidism as the single major component for decades of autoimmune polyglandular syndrome type 1
- Biochemistry of Vitamin B: Metabolic Regulations, Deficiency Disorders and Emerging Therapeutic Strategies